A clinical formulation indicated for Neurology. This medication supports cognitive function by balancing neurotransmitters to manage symptoms related to memory loss and confusion.
Formulated to manage Alzheimer's symptoms by addressing neurotransmitter imbalances to support cognitive function and alleviate daily behavioral challenges in dementia patients effectively.
Mechanism of Action
This combination drug increases acetylcholine levels and regulates glutamate activity. Donepezil prevents the breakdown of memory-related chemicals, while memantine protects nerve cells from excessive stimulation that leads to cell death.
Route of Administration
Oral
Onset Time
Weeks for noticeable effect
Duration
24 hours
Contraindications
Severe kidney impairment, Severe liver impairment, Hypersensitivity to donepezil or memantine
Severe Adverse Events
Severe bradycardia (slow heart), Seizures, Stomach ulcers/bleeding, Severe allergic reactions, Fainting, Urinary blockage
Common Side Effects
Headache, Mild nausea
Uncommon Side Effects
Dizziness, Diarrhea, Loss of appetite, Vomiting, Insomnia, Confusion
Information for Namzaric is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
